), both peptides could be found in arterial blood. 1 The calculated blood clearance rates of these two smaller fragments of angiotensin were
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Methods
Experiments were performed on 10 conscious Merino sheep: six ewes (weighing 35-42 kg) and four wethers (40.5-46 kg). These animals were housed in separate metabolism cages, and fed daily with 0.8 kg of a mixture of lucerne and oaten chaff (1:3) with free access to water; this diet contained 80-100 mEq sodium and 250-350 mEq potassium. All animals had bilateral carotid loops prepared at least 6 weeks prior to experimentation. Animals were sodium-depleted by uncompensated loss of saliva for 48 hours through a parotid duct cannula. 8 Blood Sampling
Arterial and central venous blood samples (in triplicate) were taken simultaneously into 3 volumes of ethanol at room temperature, mixed, and stored at -20°C until assayed. The volume of blood taken for each sample ranged from 15 ml in sodium-replete sheep to 10 ml in sodium-depleted sheep and for those taken during angiotensin infusion. Arterial blood was obtained from the carotid artery by direct needle puncture, and central venous blood was drawn rapidly through a 35 mm cannula positioned in the right atrium into a plastic syringe and transferred immediately into ethanol.
Infusions
In the first series of experiments, [Val'JAII was continuously infused into the pulmonary artery of sodium-depleted wethers at a rate of 42 nmoles/hr for 60 minutes. The infusate was made up to 2 nmoles/ml with 0.9% saline solution containing 0.05% ovine-7-globulin. Samples were taken simultaneously from the carotid artery and the right atrium before and 60 minutes after the commencement of infusion. When the infusion was completed, the animal was allowed to rest until its blood pressure and heart rate returned to preinfusion values. A second infusion of [Val']AIII (2) (3) (4) (5) (6) (7) (8) at a rate of 42 nmoles/hr followed. Both arterial and central venous samples were again taken before and just prior to the end of the 60-minute infusion.
Extraction of Angiotensin
Extraction of angiotensin from blood was performed within 2 weeks of collection. Previous studies have indicated that the ethanolic blood mixture can be stored at -20°C for at least 3 months without apparent change in All concentration. 4 The triplicate blood samples for measurement of AI, [Val 5 ]AII, and [Val 5 ]AIII(2-8) were handled individually. On the day of extraction, approximately 1000 cpm of either 1U I-AI (~ 1 fmole), or 'H-AII (~ 50 fmole), or 'H-AIII (2-8) (~ 30 fmole) in 0.5 ml diluent solution (0.1% human serum albumin, 0.01% merthiolate, and 0.002% neomycin sulphate in 0.1 M phosphate buffer, pH = 7.4) were added to sample. The tracer was allowed to mix and equilibrate with the ethanolic blood mixture for 20 minutes before the start of extraction. The method of extraction of angiotensin from whole blood was similar to the procedure described previously. 1 The ethanolic blood mixture was centrifuged at 1000 X g for 10 minutes, and the supernatent collected into siliconized glass containers. The residues were resuspended in 70% ethanol and centrifuged. The supernatents were pooled, and an equal volume of diethyl ether added. With occasional shaking, the mixture was left standing at room temperature for 2 hours before filtration through Whatman No. 1 filter paper into a separating funnel. The filtrate was acidified to pH 2.5, and an equal volume of distilled water was added. With vigorous shaking, the mixture solution was separated into two phases. The colored ether layer was discarded. The aqueous layer was rewashed with an equal volume of diethyl ether. The pH of the aqueous phase was then adjusted to pH 3 with 1 M NaOH solution and transferred onto a 10 X 30 mm column of SP-Sephadex C50 (Pharmacia, Sweden), which was equilibrated in 0.05 M acetic acid (pH 3). When the sample was absorbed completely, the column was eluted with 2.7 ml of diluent, discarding the first 0.7 ml. The eluate containing AI was counted to correct for losses that occurred during the extraction procedure. Plasma renin concentration (PRC) was determined by radioimmunoassay of AI production, using an antibody capture technique* developed by Poulsen and Jorgensen.'
Statistical Analysis
Unless otherwise stated, all results were expressed as means ± standard error of the mean. Student's paired t test was performed when required. For the analysis of ratios, the Wilcoxon rank sum test was used.
Results
Reliability of Anglotensin Assays
To determine the accuracy of the method for assaying AI, known amounts of AI (ranging from 500 to 2 pmoles) were added to arterial blood samples taken from sodium-loaded sheep. With 1M I-AI as an internal marker, the samples were extracted, concentrated, and assayed. Figure 1 shows the measured level of AI in the blood, after correction for losses during extraction, plotted against the added AI to the blood samples. There was a linear relationship, with a correlation coefficient of 0.99 (p < 0.001).
For the chromatographic method used to determine [Val']AII and [Val 8 ]AIII(2-8), the recovery of 2 pmoles of each peptide in the blood was 96% ± 2% (n = 6) and 108% ± 5% (n = 5) respectively. Figure 2 shows the result of radioimmunoassay of eluates following paper chromatography of arterial (2) (3) (4) (5) (6) (7) (8) in arterial and central venous blood taken before and after sodium depletion. These blood concentrations, corrected for losses during extraction and chromatography, are expressed as fmole per ml of blood. All three angiotensins were significantly (p < 0.001) elevated after 24 hours sodium depletion by uncompensated salivary loss. With the exception of AI in the sodium-replete sheep, there was a significant concentration gradient across the pulmonary circulation for all three peptidcs in both the sodium-replete and sodium-depleted state. 8 ]AIII(2-8) obtained before and after sodium depletion. The mean artcriovenous ratio (A:V) for AI was significantly different (p < 0.001) between the sodium-replete (0.80 ± 0.03, n = 7) and sodium-depleted state (0.48 ± 0.03, n = 9). There was no significant difference of arteriovenous ratios of [Val'JAII before and after sodium depletion (1.28 ± 0.06, n = 9 vs 1.30 ± 0.05, n = 16). Similarly, the arteriovenous ratio for [Val ]AII before infusion was 1.24 ± 0.12 (n = 6). It was significantly elevated to 2.09 ± 0.28 (n = 5) just prior to the end of 1 hour of infusion of [Val'JAII at 42 nmoles/hr. 
Chromatographic Profile of Arterial and Central Venous Blood Extract
Effect of Sodium Depletion on Blood Anglotensin Concentration
Model of Steady-State Angiotensin Metabolism
The experimental results (tables 1 and 2) obtained above allowed construction of a steady-state model of the production and fate of the various angiotensins as they moved through the circulation in sodiumdeficient sheep. It was assumed that the cardiac output remained constant. fig. 3) . The model is easy to construct because of the high concentrations of angiotensin during sodium deficiency; moreover, preliminary results indicate that it also is applicable to sodium-replete sheep.
It is of interest that there is a significant decrease of the arteriovenous ratio of AI with progressive sodium depletion (from 0.80 sodium-replete to 0.48 sodiumdeplete). We have reported previously that the in vivo conversion of AI to All by the lung in sheep may vary from 54% to 107%.' Although the cause of this variability in conversion was not known, the present study suggests that the rate of conversion of AI to AI I is influenced by the sodium status of the animal.
At 10 This latter study showed that a delay of up to 4 minutes in the collection of venous blood may result in an increase of 50% of total venous immunoreactivity prior to infusion, while during infusions, total venous immunoreactive material may decrease by 10%. In our present study, however, particular care was taken in the collection of central venous blood; it was drawn into a plastic syringe and immediately transferred into ethanol. The whole procedure took less than 20 seconds to collect 10 ml of central venous blood. Other experiments incubating blood at 37°C and measuring AI, [Val'JAII, and [Val 8 ]AIII(2-8) production with time would indicate that increased time in the venous circulation would not give rise to the results above, except for some production of AI.
From qualitative studies in sheep reported earlier, 31 -M it was suggested that the concentration of All in venous blood was small. Using more sophisticated methodology and especially recovery tracers, we have shown here that the arterial and central venous profiles are very similar. The chromatographic separation used has better resolution than that used previously, and the All assay is also more sensitive. In man, it also has been shown that the immunoreactive profile of arterial and venous blood are very similar."
The level of AIII(2-8) in arterial blood relative to All has been reported to be high in rats" and low in dog 88 There is both in vitro™ and in vivo"' 80 evidence to support the hypothesis that the production of AIII(2-8) may occur via a pathway involving the production of [des-Asp']AI from AI, and its subsequent conversion by converting enzyme to form AIII (2) (3) (4) (5) (6) (7) (8) . It has recently been reported that [des-Asp']AI can be produced from AI in the isolated pulmonary vascular bed of the rat. 81 This paper suggests that angiotensinase activity in rat lung may degrade specifically the amino-terminal of AI. In our present model, the pulmonary production of [ 
